122 research outputs found

    Relay Selection Considering Successive Packets Transmission in Cooperative Communication Networks

    Get PDF
    Relay selection has been regarded as an effective method to improve the performance of cooperative communication system. However, frequent operation of relay selection can bring enormous control message overhead and thereby decrease the performance of cooperative communication. To reduce the relay selection frequency, in this paper, we propose a relay selection scheme to choose the best relay with considering successive packets transmission. In this scheme, according to the length of data packet, data transmission rate and the estimated channel state information (CSI), the best relay is selected to maximize the number of successive packets transmission under the condition that the given symbol-error-rate (SER) is kept. Finally, numerical results show that the proposed relay selection scheme can support the operation of successive packets transmission in cooperative wireless networks and that the maximum number of successive packets transmission is affected by the different network parameters, i.e., data transmission rate, packet length and Doppler frequency at one relay node

    Deep CFHT Y-band imaging of VVDS-F22 field: I. data products and photometric redshifts

    Full text link
    We present our deep YY-band imaging data of a two square degree field within the F22 region of the VIMOS VLT Deep Survey. The observations were conducted using the WIRCam instrument mounted at the Canada--France--Hawaii Telescope (CFHT). The total on-sky time was 9 hours, distributed uniformly over 18 tiles. The scientific goals of the project are to select faint quasar candidates at redshift z>2.2z>2.2, and constrain the photometric redshifts for quasars and galaxies. In this paper, we present the observation and the image reduction, as well as the photometric redshifts that we derived by combining our YY-band data with the CFHTLenS ugrizu^*g'r'i'z' optical data and UKIDSS DXS JHKJHK near-infrared data. With JJ-band image as reference total \sim80,000 galaxies are detected in the final mosaic down to YY-band 5σ5\sigma point source limiting depth of 22.86 mag. Compared with the \sim3500 spectroscopic redshifts, our photometric redshifts for galaxies with z<1.5z<1.5 and i24.0i'\lesssim24.0 mag have a small systematic offset of Δz0.2|\Delta{z}|\lesssim0.2, 1σ\sigma scatter 0.03<σΔz<0.060.03<\sigma_{\Delta z} < 0.06, and less than 4.0% of catastrophic failures. We also compare to the CFHTLenS photometric redshifts, and find that ours are more reliable at z0.6z\gtrsim0.6 because of the inclusion of the near-infrared bands. In particular, including the YY-band data can improve the accuracy at z1.02.0z\sim 1.0-2.0 because the location of the 4000\AA-break is better constrained. The YY-band images, the multi-band photometry catalog and the photometric redshifts are released at \url{http://astro.pku.edu.cn/astro/data/DYI.html}.Comment: 16 pages, 12 figures, 4 tables. AJ accepted. Updated access to the data: https://zenodo.org/record/140003

    Automatic Truss Design with Reinforcement Learning

    Full text link
    Truss layout design, namely finding a lightweight truss layout satisfying all the physical constraints, is a fundamental problem in the building industry. Generating the optimal layout is a challenging combinatorial optimization problem, which can be extremely expensive to solve by exhaustive search. Directly applying end-to-end reinforcement learning (RL) methods to truss layout design is infeasible either, since only a tiny portion of the entire layout space is valid under the physical constraints, leading to particularly sparse rewards for RL training. In this paper, we develop AutoTruss, a two-stage framework to efficiently generate both lightweight and valid truss layouts. AutoTruss first adopts Monte Carlo tree search to discover a diverse collection of valid layouts. Then RL is applied to iteratively refine the valid solutions. We conduct experiments and ablation studies in popular truss layout design test cases in both 2D and 3D settings. AutoTruss outperforms the best-reported layouts by 25.1% in the most challenging 3D test cases, resulting in the first effective deep-RL-based approach in the truss layout design literature.Comment: IJCAI2023. The codes are available at https://github.com/StigLidu/AutoTrus

    Functional Characterization of the Arabidopsis β-Ketoacyl-Coenzyme A Reductase Candidates of the Fatty Acid Elongase

    Get PDF
    In plants, very-long-chain fatty acids (VLCFAs; \u3e18 carbon) are precursors of sphingolipids, triacylglycerols, cuticular waxes, and suberin. VLCFAs are synthesized by a multiprotein membrane-bound fatty acid elongation system that catalyzes four successive enzymatic reactions: condensation, reduction, dehydration, and a second reduction. A bioinformatics survey of the Arabidopsis (Arabidopsis thaliana) genome has revealed two sequences homologous to YBR159w encoding a Saccharomyces cerevisiae β-ketoacyl reductase (KCR), which catalyzes the first reduction during VLCFA elongation. Expression analyses showed that both AtKCR1 and AtKCR2 genes were transcribed in siliques, flowers, inflorescence stems, leaves, as well as developing embryos, but only AtKCR1 transcript was detected in roots. Fluorescent protein-tagged AtKCR1 and AtKCR2 were localized to the endoplasmic reticulum, the site of fatty acid elongation. Complementation of the yeast ybr159Δ mutant demonstrated that the two KCR proteins are divergent and that only AtKCR1 can restore heterologous elongase activity similar to the native yeast KCR gene. Analyses of insertional mutants in AtKCR1 and AtKCR2 revealed that loss of AtKCR1 function results in embryo lethality, which cannot be rescued by AtKCR2 expression using the AtKCR1 promoter. In contrast, a disruption of the AtKCR2 gene had no obvious phenotypic effect. Taken together, these results indicate that only AtKCR1 is a functional KCR isoform involved in microsomal fatty acid elongation. To investigate the roles of AtKCR1 in postembryonic development, transgenic lines expressing RNA interference and overexpression constructs targeted against AtKCR1 were generated. Morphological and biochemical characterization of these lines confirmed that suppressed KCR activity results in a reduction of cuticular wax load and affects VLCFA composition of sphingolipids, seed triacylglycerols, and root glycerolipids, demonstrating in planta that KCR is involved in elongation reactions supplying VLCFA for all these diverse classes of lipids

    Re-visiting the extended Schmidt law: the important role of existing stars in regulating star formation

    Get PDF
    We revisit the proposed extended Schmidt law (Shi et al. 2011) which points that the star formation efficiency in galaxies depends on the stellar mass surface density, by investigating spatially-resolved star formation rates (SFRs), gas masses and stellar masses of star formation regions in a vast range of galactic environments, from the outer disks of dwarf galaxies to spiral disks and to merging galaxies as well as individual molecular clouds in M33. We find that these regions are distributed in a tight power-law as Sigma_SFR ~(Sigma_star^0.5 Sigma_gas )^1.09, which is also valid for the integrated measurements of disk and merging galaxies at high-z. Interestingly, we show that star formation regions in the outer disks of dwarf galaxies with Sigma_SFR down to 10^(-5) Msun/yr/kpc^2, which are outliers of both Kennicutt-Schmidt and Silk-Elmegreen law, also follow the extended Schmidt law. Other outliers in the Kennicutt-Schmidt law, such as extremely-metal poor star-formation regions, also show significantly reduced deviations from the extended Schmidt law. These results suggest an important role for existing stars in helping to regulate star formation through the effect of their gravity on the mid-plane pressure in a wide range of galactic environments.Comment: 15 pages, 6 figures, 3 tables; ApJ in pres

    Case Report: Extragonadal Yolk Sac Tumors Originating From the Endometrium and the Broad Ligament: A Case Series and Literature Review

    Get PDF
    Yolk sac tumors (YSTs) of the endometrium and the broad ligament are very rare, with only 29 cases and one case of each other reported before in the English literature. Due to lack of standard guidelines, the treatment strategies of these diseases are controversial. Here, we share two cases of YSTs originating from the endometrium and the broad ligament respectively and review related literature. A 35-year-old woman was diagnosed with endometrial YST in our center and underwent surgery followed by chemotherapy with BEP (bleomycin, cisplatin and etoposide) regimen for six courses. After follow-up for 21 months, there is still no evidence of relapse. Another 36-year-old woman was admitted to our department with YST of the broad ligament. She was treated with surgery followed by chemotherapy with BEP regimen and was lost to follow-up after completing therapy. The case of endometrial YST we shared was similar to cases reported before, while the case with YST of the broad ligament we shared was the second case reported worldwide. Both of these two cases were treated with surgery combined with chemotherapy with BEP regimen

    Integrin αvβ3-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy.

    Get PDF
    RATIONALE(#br)Radiotherapy combined with immunotherapy has revealed promising outcomes in both preclinical studies and ongoing clinical trials. Targeted radionuclide therapy (TRT) is a branch of radiotherapy concerned with the use of radioisotopes, radiolabeled molecules or nanoparticles that deliver particulate radiation to cancer cells. TRT is a promising approach in cases of metastatic disease where conventional treatments are no longer effective. The increasing use of TRT raises the question of how to best integrate TRT with immunotherapy. In this study, we proposed a novel therapeutic regimen that combined programmed death ligand 1 (PD-L1)-based immunotherapy with peptide-based TRT (177Lu as the radionuclide) in the murine colon cancer model.(#br)METHODS(#br)To explore the most appropriate timing of immunotherapy after radionuclide therapy, the anti-PD-L1 antibody (αPD-L1 mAb) was delivered in a concurrent or sequential manner when 177Lu TRT was given.(#br)RESULTS(#br)The results demonstrated that TRT led to an acute increase in PD-L1 expression on T cells, and TRT in combination with αPD-L1 mAb stimulated the infiltration of CD8+ T cells, which improved local tumor control, overall survival and protection against tumor rechallenge. Moreover, our data revealed that the time window for this combination therapy may be critical to outcome.(#br)CONCLUSIONS(#br)This therapeutic combination may be a promising approach to treating metastatic tumors in which TRT can be used. Clinical translation of the result would suggest that concurrent rather than sequential blockade of the PD-1/PD-L1 axis combined with TRT improves overall survival and long-term tumor control

    Mini percutaneous nephrolithotomy is a noninferior modality to standard percutaneous nephrolithotomy for the management of 20-40 mm renal calculi: A Multicenter randomized controlled trial

    Get PDF
    Background: High quality of evidence comparing mini percutaneous nephrolithotomy (mPNL) with standard percutaneous nephrolithotomy (sPNL) for the treatment of larger-sized renal stones is lacking. Objective: To compare the efficacy and safety of mPNL and sPNL for the treatment of 20–40 mm renal stones. Design, setting, and participants: A parallel, open-label, and noninferior randomized controlled trial was performed at 20 Chinese centers (2016–2019). The inclusion criteria were patients 18–70 yr old, with normal renal function, and 20–40 mm renal stones. Intervention: Percutaneous nephrolithotomy PNL was performed using either 18 F or 24 F percutaneous nephrostomy tracts. Outcome measurements and statistical analysis: The primary outcome was the one-session stone-free rate (SFR). The secondary outcomes included operating time, visual analog pain scale (VAS) score, blood loss, complications as per the Clavien-Dindo grading system, and length of hospitalization. Results and limitations: The 1980 intention-to-treat patients were randomized. The mPNL group achieved a noninferior one-session SFR to the sPNL group by the one-side noninferiority test (0.5% [difference], p < 0.001). The transfusion and embolization rates were comparable; however, the sPNL group had a higher hemoglobin drop (5.2 g/l, p < 0.001). The sPNL yielded shorter operating time (–2.2 min, p = 0.008) but a higher VAS score (0.8, p < 0.001). Patients in the sPNL group also had longer hospitalization (0.6 d, p < 0.001). There was no statistically significant difference in fever or urosepsis occurrences. The study's main limitation was that only 18F or 24F tract sizes were used. Conclusions: Mini mPNL achieves noninferior SFR outcomes to sPNL, but with reduced bleeding, less postoperative pain, and shorter hospitalization. Patient summary: We evaluated the surgical outcomes of percutaneous nephrolithotomy using two different sizes of nephrostomy tracts in a large population. We found that the smaller tract might be a sensible alternative for patients with 20–40 mm renal stones. This multicenter, parallel, open-label, and noninferior randomized controlled trial showed that mini percutaneous nephrolithotomy achieved noninferior stone-free rate with advantages of reduced blood loss, less postoperative pain, and shorter hospitalization. Mini percutaneous nephrolithotomy should be considered a sensible alternative treatment of 20–40 mm renal stones.grants from high-level development funding of Guangzhou Medical Universit

    Substrate interaction inhibits γ-secretase production of amyloid-β peptides

    Get PDF
    Combining NMR, mass spectrometry, AlphaLISA and cell assays, we discovered a compound C1 that binds C-terminal juxtamembrane lysines at the transmembrane domain of the amyloid precursor protein (APPTM) and inhibits γ-secretase production of amyloid-β with μM IC50. Our work suggests that targeting APPTM is a novel and viable strategy in AD drug discovery.This work was supported by a grant from the Warren Alpert Foundation (to C. W.), the NIH grant R21-NS109926 (to C. W.), NIH grants R01-AG008200 and RF1-NS047229 (to N. K. R.), and the NIH grant R35-GM127040 (to Y. Z.)Peer reviewe
    corecore